| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Mycobacterium tuberculosis (isoniazid-resistant) |
- |
- |
0.06 － ? |
Moxifloxacin (BAY 12-8039, Avelox)  |
993 |
| Mycobacterium tuberculosis (isoniazid-resistant) |
- |
- |
0.125 － ? |
BB-3497 |
620 |
| Mycobacterium tuberculosis (isoniazid-resistant) |
- |
- |
>8 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
993 |
| Mycobacterium tuberculosis (isoniazid-resistant) |
- |
- |
50 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
168 |
| Mycobacterium tuberculosis (levofloxacin-resistant) |
0.78 |
1.56 |
? － ? |
Sitafloxacin |
301 |
| Mycobacterium tuberculosis (levofloxacin-resistant) |
0.78 |
3.13 |
? － ? |
Gatifloxacin (Tequin) |
301 |
| Mycobacterium tuberculosis (levofloxacin-resistant) |
3.13 |
12.5 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
301 |
| Mycobacterium tuberculosis (levofloxacin-resistant) |
6.25 |
25 |
? － ? |
Clarithromycin (Biaxin) |
301 |
| Mycobacterium tuberculosis (levofloxacin-resistant) |
6.25 |
50 |
? － ? |
Olamufloxacin (HSR-903) |
301 |
| Mycobacterium tuberculosis (levofloxacin-resistant) |
>25 |
>100 |
? － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
301 |
| Mycobacterium tuberculosis (levofloxacin-resistant) |
25 |
100 |
? － ? |
Rifampicin (Rifampin) |
301 |
| Mycobacterium tuberculosis (levofloxacin-susceptible) |
0.1 |
0.1 |
? － ? |
Sitafloxacin |
301 |
| Mycobacterium tuberculosis (levofloxacin-susceptible) |
0.1 |
0.2 |
? － ? |
Gatifloxacin (Tequin) |
301 |
| Mycobacterium tuberculosis (levofloxacin-susceptible) |
0.1 |
6.25 |
? － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
301 |
| Mycobacterium tuberculosis (levofloxacin-susceptible) |
0.1 |
100 |
? － ? |
Rifampicin (Rifampin) |
301 |
| Mycobacterium tuberculosis (levofloxacin-susceptible) |
0.39 |
0.78 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
301 |
| Mycobacterium tuberculosis (levofloxacin-susceptible) |
0.78 |
1.56 |
? － ? |
Olamufloxacin (HSR-903) |
301 |
| Mycobacterium tuberculosis (levofloxacin-susceptible) |
25 |
50 |
? － ? |
Clarithromycin (Biaxin) |
301 |
| Mycobacterium tuberculosis (multidrug drug resistant) |
- |
- |
2 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
993 |
| Mycobacterium tuberculosis (multidrug drug resistant) |
- |
- |
4 － ? |
Isoniazid (INH, Laniazid, Nydrazid, Rifamate) |
993 |
| Mycobacterium tuberculosis (multidrug-resistant) |
0.39 |
1.56 |
? － ? |
Gatifloxacin (Tequin) |
301 |
| Mycobacterium tuberculosis (multidrug-resistant) |
0.39 |
1.56 |
? － ? |
Sitafloxacin |
301 |
| Mycobacterium tuberculosis (multidrug-resistant) |
1 |
2 |
? － ? |
Grepafloxacin (Raxar) |
994 |
| Mycobacterium tuberculosis (multidrug-resistant) |
3.13 |
6.25 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
301 |
| Mycobacterium tuberculosis (multidrug-resistant) |
3.13 |
25 |
? － ? |
Olamufloxacin (HSR-903) |
301 |
| Mycobacterium tuberculosis (multidrug-resistant) |
6.25 |
25 |
? － ? |
Clarithromycin (Biaxin) |
301 |
| Mycobacterium tuberculosis (multidrug-resistant) |
>8 |
>8 |
4 － >8 |
A-80556 |
994 |
| Mycobacterium tuberculosis (multidrug-resistant) |
>8 |
>8 |
>8 － ? |
Tosufloxacin |
994 |